AARST_Radon_Reporter_July_2023

18 | July 2023 MEDICAL Radon Report Card: Spotlight on the Cost of Cancer and Radon-Induced Lung Cancer AARST has updated the Radon Report Card to include the cost of radon-induced lung cancer (see Iowa's report card above; see all states' repot cards at https://aarst.org/report-card ) . Each state’s report card now presents, along with the estimated number of radon-induced lung cancer cases, the total cost for such incidence in the state, based on US National Cancer Institute research, for: • Medical and prescription drug costs for each radon-induced lung cancer patient - $201,000 • Lost earnings / productivity and cost to society / families for each case - $210,000 The cost of radon-induced lung cancer in all 50 states is $5.9 billion for patient care (medical and prescription drugs) and $6.2 billion in economic costs (lost earnings/productivity and societal/family). The remainder of this article breaks down the source material behind each figure.